⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19867756 | 0.75 | — | — | |
| SCHEMBL18434563 | 0.72 | — | — | |
| SCHEMBL14315549 | 0.71 | — | — | |
| SCHEMBL21983782 | 0.71 | — | — | |
| SCHEMBL24942982 | 0.71 | — | — | |
| SCHEMBL21673010 | 0.70 | — | — | |
| SCHEMBL21888618 | 0.70 | — | — | |
| SCHEMBL1130031 | 0.70 | — | — | |
| SCHEMBL18520349 | 0.69 | — | — | |
| SCHEMBL29699850 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11059814-B2 | Kinase inhibitors and methods for making and using | RIGEL PHARMACEUTICALS, INC. (US) | 2021-07-13 | — | — | US | disclosed |
| US-20200181135-A1 | KINASE INHIBITORS AND METHODS FOR MAKING AND USING | RIGEL PHARMACEUTICALS, INC. (US) | 2020-06-11 | — | — | US | disclosed |